Background illustration for clinical trials search

Paid Clinical Trials Ontario

Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase 1, Phase 2, Recruiting

FitJoints: Getting Fit for Hip and Knee Replacement

for
Hip Osteoarthritis, Knee Osteoarthritis
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 60+

Code: NCT05100966

Recruiting

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

for
Metastatic Tumor
Location: Montreal, London, Vancouver
Sponsor: David Palma

Sex: All

Age: 18+

Code: NCT05717166

Phase 3, Recruiting

Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose

for
Venous Thromboembolism
Location: Halifax, Philadelphia PA, Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 0 - 18

Code: NCT02486666

Phase 3, Recruiting

Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not

for
Rhegmatogenous Retinal Detachment
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT04723420

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase 3, Recruiting

Popular cities in Ontario

Toronto